Lacuesta, G. and Lee, J. K. (2022) “The Evidence and Clinical Rationale for the Use of JAK Inhibitors in the Management of AD ”, Canadian Allergy & Immunology Today. Toronto, Canada, 2(s11), pp. 3–11. doi: 10.58931/cait.2022.2s1148.